0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 21-40 of 244 Articles
JAMA Oncology | 
Research Letter | 
Scott V. Bratman, MD, PhD; Jeffrey P. Bruce, PhD; Brian O’Sullivan, MD; et al.
JAMA Oncol. 2016;2(6):823-826. doi:10.1001/jamaoncol.2015.6587.

JAMA Oncology | 
Viewpoint | 
Howard (Jack) West, MD
JAMA Oncol. 2016;2(6):717-718. doi:10.1001/jamaoncol.2016.0075.

JAMA Oncology | 
Viewpoint | 
Vivek Subbiah, MD; Razelle Kurzrock, MD
JAMA Oncol. 2016;2(6):719-720. doi:10.1001/jamaoncol.2016.0078.

JAMA Oncology | 
Review | 
Kevin Wood, MD; Thomas Hensing, MD; Raeva Malik, MD; et al.
JAMA Oncol. 2016;2(6):805-812. doi:10.1001/jamaoncol.2016.0405.
Includes: CME, Supplemental Content

JAMA Otolaryngology–Head & Neck Surgery | 
Original Investigation | 
Andrew C. Birkeland, MD; Megan Yanik, BS; Brittny N. Tillman, MD; et al.
JAMA Otolaryngol Head Neck Surg. 2016;142(6):559-567. doi:10.1001/jamaoto.2016.0335.
Includes: Supplemental Content

JAMA Dermatology | 
Brief Report |  ONLINE FIRST
John Charles Rotondo, PhD; Alessandro Borghi, MD; Rita Selvatici, PhD; et al.
JAMA Dermatol. Published online May 25, 2016. doi:10.1001/jamadermatol.2016.1336

JAMA Oncology | 
Review |  ONLINE FIRST
Corey Speers, MD, PhD; Lori J. Pierce, MD
JAMA Oncol. Published online May 12, 2016. doi:10.1001/jamaoncol.2015.5805

JAMA Otolaryngology–Head & Neck Surgery | 
Viewpoint | 
Russell B. Smith, MD; Robert L. Ferris, MD, PhD
JAMA Otolaryngol Head Neck Surg. 2016;142(5):421-422. doi:10.1001/jamaoto.2016.0142.

JAMA Oncology | 
Brief Report | 
Bhavani Krishnan, PhD; Tracy L. Rose, MD, MPH; Jordan Kardos, BS; et al.
JAMA Oncol. 2016;2(5):664-667. doi:10.1001/jamaoncol.2016.0005.
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Nathan A. Pennell, MD, PhD
JAMA Oncol. 2016;2(5):569-570. doi:10.1001/jamaoncol.2016.0040.

JAMA Oncology | 
Viewpoint | 
Aaron Lisberg, MD; Edward B. Garon, MD
JAMA Oncol. 2016;2(5):571-572. doi:10.1001/jamaoncol.2016.0043.

JAMA Oncology | 
Editorial | 
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncol. 2016;2(5):578-579. doi:10.1001/jamaoncol.2015.6274.

JAMA Oncology | 
Original Investigation | 
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Oncol. 2016;2(5):633-642. doi:10.1001/jamaoncol.2015.6065.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Ji Won Ahn, BA; Katherine Johnson, DO; Laurie L. Kohen, MD; et al.
JAMA Dermatol. 2016;152(5):584-586. doi:10.1001/jamadermatol.2015.5702.

JAMA Oncology | 
Invited Commentary | 
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncol. 2016;2(5):653-654. doi:10.1001/jamaoncol.2015.5226.

JAMA Oncology | 
Original Investigation | 
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.
JAMA Oncol. 2016;2(5):643-653. doi:10.1001/jamaoncol.2015.5225.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Guo Chen, PhD; Jennifer L. McQuade, MD; David J. Panka, PhD; et al.
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0509
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0339
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Mark D. Pegram, MD
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0238

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Ahmad Awada, MD, PhD; Ramon Colomer, MD, PhD; Kenichi Inoue, MD; et al.
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0237
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
Routine Cancer Antigen 125 Surveillance—The Fatal Attraction of Testing
James S. Goodwin, MD
JAMA Oncology
Original Investigation  | 
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers Insights From a Precision Oncology Sequencing Platform
Luc G. T. Morris, MD, MSc; Raghu Chandramohan, MSc; Lyndsay West, BA; et al.
JAMA Oncology
Original Investigation  | 
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer
Katharine M. Esselen, MD, MBA; Angel M. Cronin, MS; Kristin Bixel, MD; et al.
JAMA Surgery
Review  | 
Molecular-Directed Treatment of Differentiated Thyroid Cancer Advances in Diagnosis and Treatment
Linwah Yip, MD; Julie Ann Sosa, MD, MA